Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study by Pivot, X., Spano, J.P., Espie, M., Cottu, P., Jouannaud, C., Pottier, V., Moreau, L., Extra, J.M., Lortholary, A., Rivera, P., Spaeth, D., Attar-Rabia, H., Benkanoun, C., Dima-Martinez, L., Esposito, N., Gligorov, J.

Get full text

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group by Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I

Get full text

Cabazitaxel in patients with advanced solid tumours: Results of a Phase I and pharmacokinetic study by Diéras, V, Lortholary, A, Laurence, V, Delva, R, Girre, V, Livartowski, A, Assadourian, S, Semiond, D, Pierga, J.Y

Get full text

Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network by Derquin, F., Floquet, A., Hardy-Bessard, A.C., Edeline, J., Lotz, J.P., Alexandre, J., Pautier, P., Angeles, M.A., Delanoy, N., Lefeuvre-Plesse, C., Cancel, M., Treilleux, I., Augereau, P., Lavoue, V., Kalbacher, E., Berton Rigaud, D., Selle, F., Nadeau, C., Gantzer, J., Joly, F., Guillemet, C., Pomel, C., Favier, L., Abdeddaim, C., Venat-Bouvet, L., Provansal, M., Fabbro, M., Kaminsky, M.C., Lortholary, A., Lecuru, F., Coquard, I. Ray, de La Motte Rouge, T.

Get full text

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial by Gross-Goupil, M, Fourcade, A, Blot, E, Penel, N, Négrier, S, Culine, S, Chaigneau, L, Lesimple, T, Priou, F, Lortholary, A, Kaminsky, M.C, Provencal, J, Voog, E, Bouzy, J, Laplanche, A, Fizazi, K

Get full text

Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA by Spano, J.-P, Beuzeboc, P, Coeffic, D, Arnould, L, Lortholary, A, Andre, F, Ferrero, J.-M

Get full text

2755 First real life data on Olaparib in BRCA1/2 mutated Platinum-Sensitive Relapsed (PSR) Epithelial Ovarian Cancer (EOC) in France: Analysis of 52 patients (pts) enrolled in the... by De La Motte Rouge, T, Pautier, P, Alexandre, J, Ray-Coquard, I, Cottu, P, Rodrigues, M, Follana, P, Floquet, A, Lortholary, A, Heudel, P.E, Combe, P, Joly, F, Suau, D, Maribas, D, Licour, M, Porte, I. De La, Varoqueaux, N, Pujade-Lauraine, E

Get full text

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial by Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, O'Malley, David M, Armstrong, Deborah K, Garcia-Donas, Jesus, Swisher, Elizabeth M, Floquet, Anne, Konecny, Gottfried E, McNeish, Iain A, Scott, Clare L, Cameron, Terri, Maloney, Lara, Goble, Sandra, Grace, Caroline, Harding, Thomas C, Raponi, Mitch, Sun, James, Lin, Kevin K, Giordano, Heidi, Ledermann, Jonathan A, Buck, M, Dean, A, Friedlander, M L, Harnett, P, Scott, C L, Dirix, L, Vergote, I, Elit, L, Ghatage, P, Oza, A M, Plante, M, Provencher, D, Weberpals, J I, Floquet, A, Joly, F, Leary, A, Medioni, J, Tredan, O, You, B, El-Balat, A, Hänle, C, Krabisch, P, Neunhöffer, T, Pölcher, M, Wimberger, P, Amit, A, Kovel, S, Leviov, M, Safra, T, Shapira-Frommer, R, Stemmer, S, Bologna, A, Colombo, N, Lorusso, D, Sabbatini, R F, Scambia, G, Tamberi, S, Zamagni, C, Fong, P C, O'Donnell, A, Gancedo, M Amenedo, Garcia-Donas, J, Guerra, E M, Oaknin, A, Palacio, I, Romero, I, Sanchez, A, Banerjee, S N, Drew, Y, Jackson, D, Ledermann, J A, McNeish, I A, Parkinson, C, Powell, M, Buss, M K, Chambers, S K, Chen, L-m, Coleman, R L, Holloway, R W, Konecny, G E, Ma, L, Morgan, M A, Morris, R T, O'Malley, D M, Slomovitz, B M, Swisher, E M, Vanderkwaak, T, Vulfovich, M

Get full text

A Dose‐Finding Study of Zoledronate in Hypercalcemic Cancer Patients by Body, J. J., Lortholary, A., Romieu, G., Vigneron, A. M., Ford, J.

Get full text

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies by Fischer, Alain, Provot, Johan, Jais, Jean-Philippe, Alcais, Alexandre, Mahlaoui, Nizar, Adoue, Daniel, Aladjidi, Nathalie, Amoura, Zahir, Arlet, Philippe, Armari-Alla, Corinne, Bader-Meunier, Brigitte, Barlogis, Vincent, Bayart, Sophie, Beaurain, Beatrice, Bertrand, Yves, Blanche, Stéphane, Bodet, Damien, Bonnotte, Bernard, Borie, Raphaël, Briandet, Claire, Brion, Jean-Paul, Brouard, Jacques, Catherinot, Emilie, Chandesris, Olivia, Cohen-Beaussant, Sarah, Costes, Laurence, Couderc, Louis-Jean, Couillault, Gérard, de Saint Basile, Geneviève, de Vergnes, Nathalie, Devoldere, Catherine, Donadieu, Jean, Dore, Eric, Dulieu, Fabienne, Durieu, Isabelle, Edan, Christine, Entz Werle, Natacha, Fouyssac, Fanny, Frange, Pierre, Gajdos, Vincent, Galicier, Lionel, Gandemer, Virginie, Gaud, Catherine, Grosbois, Bernard, Hachulla, Eric, Hamidou, Mohamed, Héritier, Sébastien, Hermine, Olivier, Hoarau, Cyrille, Hoen, Bruno, Humbert, Sébastien, Jaccard, Arnaud, Jais, Jean-Philippe, Jaussaud, Rolland, Jeziorski, Eric, Kebaili, Kamila, Korganow, Anne-Sophie, Lambotte, Olivier, Lanternier, Fanny, Le Moing, Vincent, Lecuit, Marc, Lefevre, Guillaume, Lemal, Richard, Le Moine, Philippe, Li Thiao Te, Valérie, Lortholary, Olivier, Lutz, Patrick, Magerus-Chatinet, Aude, Marie-Cardine, Aude, Martin Silva, Nicolas, Masseau, Agathe, Massot, Christian, Merlin, Etienne, Michel, Gérard, Minckes, Odile, Neven, Bénédicte, Nove-Josserand, Raphaëlle, Ouachée-Chardin, Marie, Pagnier, Anne, Pasquali, Jean-Louis, Pasquet, Marlène, Pellier, Isabelle, Perel, Yves, Perlat, Antoinette, Picard, Capucine, Piguet, Christophe, Plantaz, Dominique, Rieux-Laucat, Frédéric, Roblot, Pascal, Roger, Pierre-Marie, Royer, Bruno, Salle, Valéry, Sarrot-Reynauld, Françoise, Servettaz, Amélie, Stephan, Jean-Louis, Schleinitz, Nicolas, Taque, Sophie, Thomas, Caroline, Tournilhac, Olivier, Vannier, Jean-Pierre

Get full text

Significant contribution of germline BRCA2 rearrangements in male breast cancer families by TOURNIER, Isabelle, BRESSAC-DE PAILLERETS, Brigitte, LORTHOLARY, Alain, CHAPPUIS, Pierre, BOURDON, Violaine, BONADONA, Valérie, MAUGARD, Christine, GILBERT, Brigitte, NOGUES, Catherine, FREBOURG, Thierry, TOSI, Mario, SOBOL, Hagay, STOPPA-LYONNET, Dominique, LIDEREAU, Rosette, BARROIS, Michel, MAZOYER, Sylvie, COULET, Florence, HARDOUIN, Agnès, CHOMPRET, Agnès

Get full text

Clinical picture and treatment of 2212 patients with common variable immunodeficiency by Gathmann, Benjamin, MA, Mahlaoui, Nizar, MD, MSc, MPH, Gérard, Laurence, MD, Oksenhendler, Eric, MD, Warnatz, Klaus, MD, Schulze, Ilka, MD, Kindle, Gerhard, MD, Kuijpers, Taco W., MD, van Beem, Rachel T., PhD, Guzman, David, Lic, Workman, Sarita, RN, MSc, Soler-Palacín, Pere, MD, PhD, De Gracia, Javier, MD, PhD, Witte, Torsten, MD, Schmidt, Reinhold E., MD, Litzman, Jiri, MD, Hlavackova, Eva, MD, Thon, Vojtech, MD, PhD, Borte, Michael, MD, PhD, Borte, Stephan, MD, Kumararatne, Dinakantha, MD, Feighery, Conleth, MD, Longhurst, Hilary, FRCP, PhD, Helbert, Matthew, MD, Szaflarska, Anna, MD, Sediva, Anna, MD, Belohradsky, Bernd H., MD, Jones, Alison, MRCP, PhD, Baumann, Ulrich, MD, PhD, Meyts, Isabelle, MD, PhD, Kutukculer, Necil, MD, Wågström, Per, MD, Galal, Nermeen Mouftah, MD, Roesler, Joachim, MD, Farmaki, Evangelia, MD, PhD, Zinovieva, Natalia, MD, Ciznar, Peter, MD, PhD, Papadopoulou-Alataki, Efimia, MD, PhD, Bienemann, Kirsten, MD, Velbri, Sirje, MD, PhD, Panahloo, Zoya, MD, Grimbacher, Bodo, MD

Get full text

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines by Curtit, E, Nouyrigat, P, Dohollou, N, Levy, E, Lortholary, A, Gligorov, J, Facchini, T, Jaubert, D, Maille, N, Pivot, X, Grangé, V, Cals, L

Get full text

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002) by Bugat, R, Bataillard, A, Lesimple, T, Voigt, J J, Culine, S, Lortholary, A, Merrouche, Y, Ganem, G, Kaminsky, M C, Negrier, S, Perol, M, Laforêt, C, Bedossa, P, Bertrand, G, Coindre, J M, Fizazi, K

Get full text

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial by Bernard, Louis, Prof, Dinh, Aurélien, MD, Ghout, Idir, MSc, Simo, David, CRA, Zeller, Valerie, MD, Issartel, Bertrand, MD, Le Moing, Vincent, MD, Belmatoug, Nadia, MD, Lesprit, Philippe, MD, Bru, Jean-Pierre, MD, Therby, Audrey, MD, Bouhour, Damien, MD, Dénes, Eric, MD, Debard, Alexa, MD, Chirouze, Catherine, MD, Fèvre, Karine, CRA, Dupon, Michel, MD, Aegerter, Philippe, MD, Mulleman, Denis, MD

Get full text

Carcinoma of an unknown primary: are EGF receptor, Her-2 neu, and c-Kit tyrosine kinases potential targets for therapy? by Massard, C, Voigt, J-J, Laplanche, A, Culine, S, Lortholary, A, Bugat, R, Theodore, C, Priou, F, Kaminsky, M-C, Lesimple, T, Pivot, X, Coudert, B, Douillard, J-Y, Merrouche, Y, Fizazi, K

Get full text

Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants by Bloch, Coralie, Jais, Jean Philippe, Gil, Marine, Boubaya, Marouane, Lepelletier, Yves, Bader-Meunier, Brigitte, Mahlaoui, Nizar, Garcelon, Nicolas, Lambotte, Olivier, Launay, David, Larroche, Claire, Lazaro, Estibaliz, Liffermann, Francois, Lortholary, Olivier, Michel, Marc, Michot, Jean-Marie, Morel, Pierre, Cheminant, Morgane, Suarez, Felipe, Terriou, Louis, Urbanski, Geoffrey, Viallard, Jean-Francois, Alcais, Alexandre, Fischer, Alain, de Saint Basile, Geneviève, Hermine, Olivier

Get full text

ESTIMATED COSTS OF HER2-POSITIVE METASTATIC BREAST CANCER FOR PATIENTS INITIATING AN ORAL ANTICANCER TREATMENT: RESULTS FROM A FRENCH PROSPECTIVE OBSERVATIONAL STUDY by Woronoff-Lemsi, M.C, Chaix-Couturier, C, Durand-Zaleski, I, Espié, M, Lortholary, A, Merrouche, Y, Flinois, A, Chabernaud, H, Benjamin, L

Get full text

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU by GAMELIN, E. C, DANQUECHIN-DORVAL, E. M, DUMESNIL, Y. F, MAILLART, P. J, GOUDIER, M. J, BURTIN, P. C, DELVA, R. G, LORTHOLARY, A. H, GESTA, P. H, LARRA, F. G

Get full text

The contribution of germline rearrangements to the spectrum of BRCA2 mutations by Casilli, F, Tournier, I, Sinilnikova, O M, Coulet, F, Soubrier, F, Houdayer, C, Hardouin, A, Berthet, P, Sobol, H, Bourdon, V, Muller, D, Fricker, J P, Capoulade-Metay, C, Chompret, A, Nogues, C, Mazoyer, S, Chappuis, P, Maillet, P, Philippe, C, Lortholary, A, Gesta, P, Bézieau, S, Toulas, C, Gladieff, L, Maugard, C M, Provencher, D M, Dugast, C, Delvincourt, C, Nguyen, T D, Faivre, L, Bonadona, V, Frébourg, T, Lidereau, R, Stoppa-Lyonnet, D, Tosi, M

Get full text